{"id":675210,"date":"2023-11-03T19:36:01","date_gmt":"2023-11-03T19:36:01","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=675210"},"modified":"2023-11-03T19:36:01","modified_gmt":"2023-11-03T19:36:01","slug":"alcohol-use-disorder-pipeline-clinical-trials-key-companies-adial-pharmaceuticals-arbor-pharmaceuticals-gilead-sciences","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/alcohol-use-disorder-pipeline-clinical-trials-key-companies-adial-pharmaceuticals-arbor-pharmaceuticals-gilead-sciences_675210.html","title":{"rendered":"Alcohol Use Disorder Pipeline | Clinical Trials, Key Companies – Adial Pharmaceuticals, Arbor Pharmaceuticals, Gilead Sciences"},"content":{"rendered":"
\n
\"Alcohol<\/a><\/div>\n
\n
DelveInsight Business Research LLP <\/div>\n<\/div>\n<\/div>\n
DelveInsight\u2019s, \u201cAlcohol Use Disorder Pipeline Insight, 2023,\u201d report provides comprehensive insights about 30+ companies and 30+ pipeline drugs in the Alcohol Use Disorder pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive Alcohol Use Disorder pipeline products in this space.<\/div>\n

DelveInsight’s, “Alcohol Use Disorder Pipeline Insight, 2023<\/a>,<\/strong>” report provides comprehensive insights about 30+ companies and 30+ pipeline drugs in the Alcohol Use Disorder pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive Alcohol Use Disorder pipeline products in this space.<\/p>\n

Download the sample page to learn more @ Alcohol Use Disorder <\/a><\/strong><\/p>\n

Alcohol Use Disorder Overview<\/strong><\/p>\n

Alcohol Use Disorder also referred to as Alcoholism is the most severe form of alcohol abuse and involves the inability to manage drinking habits. It is also commonly referred to as Alcohol Addiction. These are common and potentially lethal disorders that mimic and exacerbate a wide range of additional medical and psychiatric conditions and thereby shorten the lifespans of affected people by more than a decade.<\/p>\n

Symptoms are as follows- <\/strong>People with alcohol use disorder may engage in the following behaviors: Slurred speech, unsteady walking, nausea, double vision, increased heart rate, drowsiness, impairment in motor coordination and thinking ability, talkativeness, relaxation <\/p>\n

Alcohol Use Disorder Diagnosis- <\/strong>Although they are not a substitute for a careful clinical interview, a range of self-administered questionnaires can be used to screen for heavy drinking and alcohol-use disorders in clinical settings. The shortest of the most widely-used instruments is the CAGE questionnaire, which is an acronym for whether a patient has ever felt the need to cut down on drinking; felt Annoyed when criticized about alcohol use; felt Guilty about drinking, or ever needed an Eye-opener on awakening. Although not as sensitive as questionnaires, blood tests for markers that are likely to change in the context of heavy drinking can also help to identify patients who consume hazardous amounts of alcohol.<\/p>\n

Alcohol Use Disorder Epidemiological Segmentation <\/strong><\/p>\n